Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The revenue for Gulf Medical Projects Company (PJSC) as of June 30, 2025 is 711.55 MM.
- The operating income for Gulf Medical Projects Company (PJSC) as of June 30, 2025 is 66.92 MM.
- The net income for Gulf Medical Projects Company (PJSC) as of June 30, 2025 is 98.73 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 711.55 | 66.92 | 98.73 |
2025-03-31 | 690.34 | 67.51 | 83.53 |
2024-12-31 | 677.34 | 72.27 | 77.89 |
2024-09-30 | 650.98 | 66.74 | 64.98 |
2024-06-30 | 631.92 | 68.84 | 68.98 |
2024-03-31 | 600.74 | 57.65 | 63.42 |
2023-12-31 | 569.64 | 47.07 | 59.81 |
2023-09-30 | 542.08 | 34.98 | 46.53 |
2023-06-30 | 524.54 | 29.34 | 41.69 |
2023-03-31 | 515.07 | 28.18 | 34.66 |
2022-12-31 | 503.83 | 22.05 | 36.60 |
2022-09-30 | 492.87 | 20.86 | 36.23 |
2022-06-30 | 489.19 | 18.79 | 33.38 |
2022-03-31 | 486.78 | 24.15 | 38.82 |
2021-12-31 | 486.83 | 29.36 | 35.58 |
2021-09-30 | 487.70 | 31.38 | 33.40 |
2021-06-30 | 504.42 | 41.11 | 40.72 |
2021-03-31 | 481.24 | 32.82 | 34.51 |
2020-12-31 | 487.26 | 32.62 | 34.55 |
2020-09-30 | 500.27 | 30.46 | 66.45 |
2020-06-30 | |||
2020-03-31 |
Income Statement: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | 0.11 | |
2024-09-30 | 0.09 | 0.09 |
2024-06-30 | 0.10 | 0.10 |
2024-03-31 | 0.09 | 0.09 |
2023-12-31 | 0.09 | |
2023-09-30 | 0.07 | 0.07 |
2023-06-30 | 0.06 | 0.06 |
2023-03-31 | 0.05 | 0.05 |
2022-12-31 | 0.05 | |
2022-09-30 | 0.05 | 0.05 |
2022-06-30 | 0.05 | 0.05 |
2022-03-31 | 0.06 | 0.06 |
2021-12-31 | 0.05 | |
2021-09-30 | 0.05 | 0.05 |
2021-06-30 | 0.06 | 0.06 |
2021-03-31 | 0.05 | 0.05 |
2020-12-31 | 0.05 | |
2020-09-30 | 0.10 | 0.10 |
2020-06-30 | 0.09 | 0.09 |
2020-03-31 | 0.09 | 0.09 |
Cash Flow: Operations, Investing, Financing
- The cash from operating activities for Gulf Medical Projects Company (PJSC) as of June 30, 2025 is 148.11 MM.
- The cash from investing activities for Gulf Medical Projects Company (PJSC) as of June 30, 2025 is -21.82 MM.
- The cash from financing activities for Gulf Medical Projects Company (PJSC) as of June 30, 2025 is -114.25 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | 148.11 | -21.82 | -114.25 |
2025-03-31 | 159.75 | -5.11 | -114.21 |
2024-12-31 | 86.99 | -35.27 | -77.62 |
2024-09-30 | 102.66 | -35.76 | -76.14 |
2024-06-30 | 84.97 | -9.41 | -77.62 |
2024-03-31 | 51.29 | 15.61 | -77.62 |
2023-12-31 | 88.71 | -7.48 | -76.74 |
2023-09-30 | 65.99 | 9.26 | -76.72 |
2023-06-30 | 60.23 | -21.14 | -75.25 |
2023-03-31 | 83.55 | -0.12 | -75.26 |
2022-12-31 | 76.10 | 15.08 | -85.79 |
2022-09-30 | 84.19 | -0.50 | -97.93 |
2022-06-30 | 94.09 | 4.60 | -112.82 |
2022-03-31 | 90.52 | -11.59 | -124.84 |
2021-12-31 | 132.30 | -41.55 | -125.04 |
2021-09-30 | 102.98 | 7.51 | -113.64 |
2021-06-30 | 106.01 | 33.21 | -99.03 |
2021-03-31 | 92.84 | 37.09 | -101.80 |
2020-12-31 | 66.07 | 65.33 | -105.49 |
2020-09-30 | 96.53 | 36.41 | -117.85 |
2020-06-30 | |||
2020-03-31 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 | |||
2020-03-31 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 | ||
2020-06-30 | ||
2020-03-31 |
Management Effectiveness
- The roa for Gulf Medical Projects Company (PJSC) as of June 30, 2025 is 0.06.
- The roe for Gulf Medical Projects Company (PJSC) as of June 30, 2025 is 0.09.
- The roic for Gulf Medical Projects Company (PJSC) as of June 30, 2025 is 0.07.
- The croic for Gulf Medical Projects Company (PJSC) as of June 30, 2025 is 0.03.
- The ocroic for Gulf Medical Projects Company (PJSC) as of June 30, 2025 is 0.13.
Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
2025-06-30 | 0.06 | 0.09 | 0.07 | 0.03 | 0.13 |
2025-03-31 | 0.06 | 0.07 | 0.06 | -0.02 | 0.07 |
2024-12-31 | 0.05 | 0.07 | 0.06 | -0.01 | 0.09 |
2024-09-30 | 0.05 | 0.06 | 0.06 | -0.00 | 0.07 |
2024-06-30 | 0.05 | 0.06 | 0.06 | -0.01 | 0.05 |
2024-03-31 | 0.05 | 0.05 | 0.05 | 0.00 | 0.07 |
2023-12-31 | 0.04 | 0.04 | 0.04 | -0.00 | 0.08 |
2023-09-30 | 0.03 | 0.04 | 0.04 | -0.03 | 0.08 |
2023-06-30 | 0.03 | 0.04 | 0.04 | -0.03 | 0.08 |
2023-03-31 | 0.03 | 0.03 | 0.03 | 0.01 | 0.09 |
2022-12-31 | 0.03 | 0.03 | 0.03 | -0.01 | 0.07 |
2022-09-30 | 0.03 | 0.03 | 0.03 | -0.01 | 0.07 |
2022-06-30 | 0.03 | 0.03 | 0.03 | -0.01 | 0.08 |
2022-03-31 | 0.03 | 0.04 | 0.03 | -0.04 | 0.08 |
2021-12-31 | 0.03 | 0.03 | 0.03 | -0.03 | 0.11 |
2021-09-30 | 0.03 | 0.03 | 0.03 | -0.00 | 0.12 |
2021-06-30 | 0.03 | 0.04 | 0.04 | 0.04 | 0.11 |
2021-03-31 | 0.03 | 0.03 | 0.03 | 0.03 | 0.10 |
2020-12-31 | 0.02 | 0.03 | 0.03 | 0.02 | 0.08 |
2020-09-30 | 0.05 | 0.06 | 0.06 | 0.01 | 0.09 |
2020-06-30 | 0.05 | 0.06 | 0.06 | -0.01 | 0.09 |
2020-03-31 | 0.05 | 0.06 | 0.06 | 0.01 | 0.10 |
Gross Margins
- The gross margin for Gulf Medical Projects Company (PJSC) as of June 30, 2025 is 0.27.
- The net margin for Gulf Medical Projects Company (PJSC) as of June 30, 2025 is 0.12.
- The operating margin for Gulf Medical Projects Company (PJSC) as of June 30, 2025 is 0.10.
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
2025-06-30 | 0.27 | 0.12 | 0.10 |
2025-03-31 | 0.28 | 0.11 | 0.11 |
2024-12-31 | 0.27 | 0.10 | 0.10 |
2024-09-30 | 0.28 | 0.11 | 0.11 |
2024-06-30 | 0.26 | 0.11 | 0.10 |
2024-03-31 | 0.25 | 0.10 | 0.08 |
2023-12-31 | 0.24 | 0.09 | 0.06 |
2023-09-30 | 0.24 | 0.08 | 0.06 |
2023-06-30 | 0.24 | 0.08 | 0.06 |
2023-03-31 | 0.23 | 0.07 | 0.05 |
2022-12-31 | 0.23 | 0.07 | 0.04 |
2022-09-30 | 0.23 | 0.07 | 0.04 |
2022-06-30 | 0.25 | 0.07 | 0.04 |
2022-03-31 | 0.26 | 0.08 | 0.05 |
2021-12-31 | 0.26 | 0.07 | 0.06 |
2021-09-30 | 0.28 | 0.07 | 0.06 |
2021-06-30 | 0.28 | 0.08 | 0.08 |
2021-03-31 | 0.27 | 0.07 | 0.07 |
2020-12-31 | 0.26 | 0.07 | 0.07 |
2020-09-30 | 0.26 | 0.13 | 0.06 |
2020-06-30 | 0.24 | 0.13 | 0.05 |
2020-03-31 | 0.25 | 0.12 | 0.06 |
Identifiers and Descriptors
Central Index Key (CIK) |